193 related articles for article (PubMed ID: 38048028)
21. TNFAIP8 promotes the proliferation and cisplatin chemoresistance of non-small cell lung cancer through MDM2/p53 pathway.
Xing Y; Liu Y; Liu T; Meng Q; Lu H; Liu W; Hu J; Li C; Cao M; Yan S; Huang J; Wang T; Cai L
Cell Commun Signal; 2018 Jul; 16(1):43. PubMed ID: 30064446
[TBL] [Abstract][Full Text] [Related]
22. Downregulation of circular RNA hsa_circ_0087856 sensitizes bladder cancer cells to cisplatin through targeting miR-1184/CITED2 signaling.
Ju M; Wu W; Qu J; Sun Y; Li J
Environ Mol Mutagen; 2023 Jul; 64(6):342-353. PubMed ID: 37392146
[TBL] [Abstract][Full Text] [Related]
23. Abnormal expression of the mitotic checkpoint protein BubR1 contributes to the anti-microtubule drug resistance of esophageal squamous cell carcinoma cells.
Hu M; Liu Q; Song P; Zhan X; Luo M; Liu C; Yang D; Cai Y; Zhang F; Jiang F; Zhang Y; Tang M; Zuo G; Zhou L; Luo J; Shi Q; Weng Y
Oncol Rep; 2013 Jan; 29(1):185-92. PubMed ID: 23128493
[TBL] [Abstract][Full Text] [Related]
24. Checkpoint kinase 1 modulates sensitivity to cisplatin after spindle checkpoint activation in SW620 cells.
Peralta-Sastre A; Manguan-Garcia C; de Luis A; Belda-Iniesta C; Moreno S; Perona R; Sanchez-Perez I
Int J Biochem Cell Biol; 2010 Feb; 42(2):318-28. PubMed ID: 19931410
[TBL] [Abstract][Full Text] [Related]
25. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707
[TBL] [Abstract][Full Text] [Related]
26. Nearly complete deletion of BubR1 causes microcephaly through shortened mitosis and massive cell death.
Simmons AJ; Park R; Sterling NA; Jang MH; van Deursen JMA; Yen TJ; Cho SH; Kim S
Hum Mol Genet; 2019 Jun; 28(11):1822-1836. PubMed ID: 30668728
[TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNA PANDAR promoted radiation and cisplatin-induced DNA damage repair through ATR/CHK1 in NSCLC.
Zhao S; Yu N; Wang H; Wan Z; Diao C; Chen Y; Liu T; Yang Y; Gao F; Bai C; Cao K; Cai J
J Gene Med; 2023 Dec; 25(12):e3565. PubMed ID: 37460393
[TBL] [Abstract][Full Text] [Related]
28. High expression of IGHG1 promotes breast cancer malignant development by activating the AKT pathway.
Jin Y; Qiu L; Bao W; Lu M; Cao F; Ni H; Zhao B
Cell Cycle; 2023; 22(6):718-731. PubMed ID: 36404682
[TBL] [Abstract][Full Text] [Related]
29. Functional and Structural Characterization of Bub3·BubR1 Interactions Required for Spindle Assembly Checkpoint Signaling in Human Cells.
Prinz F; Puetter V; Holton SJ; Andres D; Stegmann CM; Kwiatkowski D; Prechtl S; Petersen K; Beckmann G; Kreft B; Mumberg D; Fernández-Montalván A
J Biol Chem; 2016 May; 291(21):11252-67. PubMed ID: 27030009
[TBL] [Abstract][Full Text] [Related]
30. Breast cancer-specific gene 1 interacts with the mitotic checkpoint kinase BubR1.
Gupta A; Inaba S; Wong OK; Fang G; Liu J
Oncogene; 2003 Oct; 22(48):7593-9. PubMed ID: 14576821
[TBL] [Abstract][Full Text] [Related]
31. Lentivirus-Mediated RNAi silencing targeting ERCC1 reverses cisplatin resistance in cisplatin-resistant ovarian carcinoma cell line.
Du P; Zhang X; Liu H; Chen L
DNA Cell Biol; 2015 Jul; 34(7):497-502. PubMed ID: 25941922
[TBL] [Abstract][Full Text] [Related]
32. CEP55 3'-UTR promotes epithelial-mesenchymal transition and enhances tumorigenicity of bladder cancer cells by acting as a ceRNA regulating miR-497-5p.
Yang C; Yang Y; Wang W; Zhou W; Zhang X; Xiao Y; Zhang H
Cell Oncol (Dordr); 2022 Dec; 45(6):1217-1236. PubMed ID: 36374443
[TBL] [Abstract][Full Text] [Related]
33. shRNA-induced silencing of Ras-related C3 botulinum toxin substrate 1 inhibits the proliferation of colon cancer cells through upregulation of BAD and downregulation of cyclin D1.
Huang YS; Jie N; Zhang YX; Zou KJ; Weng Y
Int J Mol Med; 2018 Mar; 41(3):1397-1408. PubMed ID: 29286138
[TBL] [Abstract][Full Text] [Related]
34. Circ-UBR1 facilitates proliferation, metastasis, and inhibits apoptosis in breast cancer by regulating the miR-1299/CCND1 axis.
Zhang L; Sun D; Zhang J; Tian Y
Life Sci; 2021 Feb; 266():118829. PubMed ID: 33259864
[TBL] [Abstract][Full Text] [Related]
35. Mitotic checkpoint genes, hsMAD2 and BubR1, in oesophageal squamous cancer cells and their association with 5-fluorouracil and cisplatin-based radiochemotherapy.
Tanaka K; Mohri Y; Ohi M; Yokoe T; Koike Y; Morimoto Y; Miki C; Tonouchi H; Kusunoki M
Clin Oncol (R Coll Radiol); 2008 Oct; 20(8):639-46. PubMed ID: 18691855
[TBL] [Abstract][Full Text] [Related]
36. A molecular basis for the differential roles of Bub1 and BubR1 in the spindle assembly checkpoint.
Overlack K; Primorac I; Vleugel M; Krenn V; Maffini S; Hoffmann I; Kops GJ; Musacchio A
Elife; 2015 Jan; 4():e05269. PubMed ID: 25611342
[TBL] [Abstract][Full Text] [Related]
37. [Biological effect of down-regulating of MTRR gene on cisplatin-resistant ovarian cancer SKOV3 cells in vitro and in vivo studies].
Chen J; Wang Q; Zhang W; Li L
Zhonghua Fu Chan Ke Za Zhi; 2016 Feb; 51(2):126-34. PubMed ID: 26917482
[TBL] [Abstract][Full Text] [Related]
38. BubR1 is required for the mitotic block induced by combretastatin-A4 and a novel cis-restricted ß-lactam analogue in human cancer cells.
Greene LM; Carr M; Keeley NO; Lawler M; Meegan MJ; Zisterer DM
Int J Mol Med; 2011 May; 27(5):715-23. PubMed ID: 21369694
[TBL] [Abstract][Full Text] [Related]
39. Long Noncoding RNA
Yao L; Chen L; Zhou H; Duan F; Wang L; Zhang Y
Cancer Biother Radiopharm; 2022 Oct; 37(8):636-649. PubMed ID: 32833504
[No Abstract] [Full Text] [Related]
40. Phylogenomics-guided discovery of a novel conserved cassette of short linear motifs in BubR1 essential for the spindle checkpoint.
Tromer E; Bade D; Snel B; Kops GJ
Open Biol; 2016 Dec; 6(12):. PubMed ID: 28003474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
